When costing and compliance collide

Only a few years ago, compliance was the undisputed top priority in the pharmaceutical industry - regardless of cost.

‘Show me the molecule’ – On synthetic biology and cutting th...

Manufacturers can streamline and speed the batch release pro...

As of late November 2024, the US Food & Drug Administration had recorded 46 voluntary drug recalls in the United States during the year, down slightly from previous years – an indicatio